"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...
SkinTE is currently available for investigational use only. Submission of a biologics license application (BLA) to the U.S. Food and Drug Administration is expected in 2026, after which additional ...
CVRx, Inc. (NASDAQ: CVRX) ('CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback